RxDoctor Payments Data

Marie Robert, MD

Anatomic Pathology & Clinical Pathology · New Haven, CTNPI 1932180221

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $114,307 of the $128,294 with a category attached, or 89.1%. 7 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 58.3% of the total. Reporting peaked in 2024 at $48,919 and has fallen 78.3% since, to $10,636 in 2025. Among anatomic pathology & clinical pathology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$128,294in general payments, 2019–2025

Across 37 payments — averaging $3467.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$75K
  • E.r. Squibb & Sons, L.L.C.$20K
  • Perspectum Diagnostics Ltd$12K
  • Incyte Corporation$11K
  • Teva Pharmaceuticals USA, Inc.$5K
  • Amgen$3K
  • plus $2K from 1 others
$8,450in research payments, 2019–2025

Across 5 payments — averaging $1690.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$8K

What the payments were for

  • Consulting fees$114,30789%
  • Speaking & faculty fees$13,87911%
  • Food & beverage$1090%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$128,294 in reported general payments places this provider in the 95th percentile of 94 anatomic pathology & clinical pathology providers in Connecticut.

See all anatomic pathology & clinical pathology providers in Connecticut

Medicare billing

Part B allowed, 2024
$32,041
Medicare patients
270
Services billed
854

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →